Frank David

1.5k total citations
23 papers, 668 citations indexed

About

Frank David is a scholar working on Molecular Biology, Economics and Econometrics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Frank David has authored 23 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Economics and Econometrics and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Frank David's work include Health Systems, Economic Evaluations, Quality of Life (8 papers), Pharmaceutical Economics and Policy (8 papers) and Cell Adhesion Molecules Research (5 papers). Frank David is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (8 papers), Pharmaceutical Economics and Policy (8 papers) and Cell Adhesion Molecules Research (5 papers). Frank David collaborates with scholars based in United States, United Kingdom and Canada. Frank David's co-authors include Benjamin G. Neel, Lewis C. Cantley, Maria Kontaridis, Heike Keilhack, Malcolm J. McGregor, Kenneth D. Swanson, David Barford, Eugene E. Marcantonio, Frank A. Provenzano and Yevgeniy Feyman and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Nature Reviews Drug Discovery.

In The Last Decade

Frank David

21 papers receiving 651 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank David United States 10 492 311 116 49 46 23 668
Hong Lü United States 9 213 0.4× 106 0.3× 100 0.9× 57 1.2× 19 0.4× 20 463
Matthew W. Strobeck United States 14 911 1.9× 158 0.5× 342 2.9× 93 1.9× 30 0.7× 17 1.1k
Lisa Watson United States 14 244 0.5× 241 0.8× 111 1.0× 56 1.1× 7 0.2× 25 665
Michelle Lui United States 8 411 0.8× 109 0.4× 81 0.7× 23 0.5× 21 0.5× 18 673
Duncan McHale United Kingdom 7 252 0.5× 171 0.5× 46 0.4× 70 1.4× 32 0.7× 10 413
Tracy Lessor United States 8 289 0.6× 177 0.6× 219 1.9× 25 0.5× 22 0.5× 8 533
Humera Khan United States 8 376 0.8× 77 0.2× 120 1.0× 51 1.0× 13 0.3× 10 521
Niya Xiong United States 12 305 0.6× 68 0.2× 256 2.2× 125 2.6× 47 1.0× 37 693
Fernanda I. Arnaldez United States 11 202 0.4× 60 0.2× 196 1.7× 84 1.7× 21 0.5× 20 513
Julie Jones United States 8 81 0.2× 76 0.2× 56 0.5× 15 0.3× 15 0.3× 15 381

Countries citing papers authored by Frank David

Since Specialization
Citations

This map shows the geographic impact of Frank David's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank David with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank David more than expected).

Fields of papers citing papers by Frank David

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank David. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank David. The network helps show where Frank David may publish in the future.

Co-authorship network of co-authors of Frank David

This figure shows the co-authorship network connecting the top 25 collaborators of Frank David. A scholar is included among the top collaborators of Frank David based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank David. Frank David is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yaeger, Rona, et al.. (2025). Surrogate end points in oncology: aligning drug development incentives and patient needs. Nature Reviews Clinical Oncology. 22(8). 617–618.
2.
3.
Feyman, Yevgeniy, Frank A. Provenzano, & Frank David. (2020). Disparities in Clinical Trial Access Across US Urban Areas. JAMA Network Open. 3(2). e200172–e200172. 27 indexed citations
4.
David, Frank, et al.. (2020). Results of a portfolio approach to intramural research funding at an academic medical center. PLoS ONE. 15(11). e0241425–e0241425. 3 indexed citations
5.
David, Frank, et al.. (2017). Trends in pharmaceutical company R&D spending: 2005–2015. Nature Reviews Drug Discovery. 16(6). 376–376. 4 indexed citations
6.
David, Frank, et al.. (2017). From innovation to market adoption in the operating room: The “CFO as customer”. Surgery. 162(3). 477–482. 3 indexed citations
7.
Downing, Nicholas S., et al.. (2017). Assessing the potential clinical impact of reciprocal drug approval legislation on access to novel therapeutics in the USA: a cohort study. BMJ Open. 7(2). e014582–e014582. 10 indexed citations
8.
Robey, Seth & Frank David. (2016). Drug launch curves in the modern era. Nature Reviews Drug Discovery. 16(1). 13–14. 5 indexed citations
9.
David, Frank, et al.. (2015). Creating value with financially adaptive clinical trials. Nature Reviews Drug Discovery. 14(8). 523–524. 4 indexed citations
10.
Palma, Catalina A., et al.. (2012). MicroRNA control of myelopoiesis and the differentiation block in acute myeloid leukaemia. Journal of Cellular and Molecular Medicine. 16(5). 978–987. 17 indexed citations
11.
12.
Citrome, Leslie, Frank David, Robert E. Enck, et al.. (2010). Authors' Submission Toolkit: A practical guide to getting your research published. Current Medical Research and Opinion. 26(8). 1967–1982. 28 indexed citations
13.
David, Frank, Luise A. Cullen‐McEwen, Xue Wu, et al.. (2010). Regulation of Kidney Development by Shp2: An Unbiased Stereological Analysis. The Anatomical Record. 293(12). 2147–2153. 2 indexed citations
14.
Partridge, Mike, Frank David, & Eugene E. Marcantonio. (2006). Displacement of the β cytoplasmic domain recovers focal adhesion formation, cytoskeletal organization and motility in swapped integrin chimeras. Journal of Cell Science. 119(6). 1175–1183. 4 indexed citations
15.
Kontaridis, Maria, Kenneth D. Swanson, Frank David, David Barford, & Benjamin G. Neel. (2005). PTPN11 (Shp2) Mutations in LEOPARD Syndrome Have Dominant Negative, Not Activating, Effects. Journal of Biological Chemistry. 281(10). 6785–6792. 231 indexed citations
16.
Keilhack, Heike, Frank David, Malcolm J. McGregor, Lewis C. Cantley, & Benjamin G. Neel. (2005). Diverse Biochemical Properties of Shp2 Mutants. Journal of Biological Chemistry. 280(35). 30984–30993. 229 indexed citations
17.
Luparello, Claudio, et al.. (2003). T47-D Cells and Type V Collagen: A Model for the Study of Apoptotic Gene Expression by Breast Cancer Cells. Biological Chemistry. 384(6). 965–75. 15 indexed citations
18.
David, Frank, Peter E. Zage, & Eugene E. Marcantonio. (1999). Integrins interact with focal adhesions through multiple distinct pathways. Journal of Cellular Physiology. 181(1). 74–82. 24 indexed citations
19.
Marcantonio, Eugene E. & Frank David. (1997). Integrin receptor signaling: The propagation of an α-helix model. Matrix Biology. 16(4). 179–184. 6 indexed citations
20.
Briesewitz, Roger, Andreas Kern, Lubomir B. Smilenov, Frank David, & Eugene E. Marcantonio. (1996). The membrane-cytoplasm interface of integrin alpha subunits is critical for receptor latency.. Molecular Biology of the Cell. 7(10). 1499–1509. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hong Lü Breakdown of academic impact, for papers by Matthew W. Strobeck Breakdown of academic impact, for papers by Lisa Watson Breakdown of academic impact, for papers by Michelle Lui Breakdown of academic impact, for papers by Duncan McHale Breakdown of academic impact, for papers by Tracy Lessor Breakdown of academic impact, for papers by Humera Khan Breakdown of academic impact, for papers by Niya Xiong Breakdown of academic impact, for papers by Fernanda I. Arnaldez Breakdown of academic impact, for papers by Julie Jones
Rankless by CCL
2026